Rapt Therapeutics, Inc.

( )
RAPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.51%64.970.0%$1005.57m
NVAXNovavax, Inc. -2.04%96.30102.0%$776.69m
AMGNAmgen, Inc. 0.03%251.661.3%$718.41m
REGNRegeneron Pharmaceuticals, Inc. 0.05%640.632.5%$682.96m
GILDGilead Sciences, Inc. -1.19%74.711.0%$611.25m
BIIBBiogen, Inc. -0.53%278.701.6%$607.56m
VRTXVertex Pharmaceuticals, Inc. -0.18%295.401.9%$486.49m
ILMNIllumina, Inc. 0.74%372.603.5%$306.35m
ALXNAlexion Pharmaceuticals, Inc. 0.44%108.472.0%$218.11m
BMRNBioMarin Pharmaceutical, Inc. -1.49%126.814.3%$211.40m
SGENSeattle Genetics, Inc. 3.21%181.176.1%$205.65m
IMMUImmunomedics, Inc. 1.81%42.3011.0%$182.18m
SRNESorrento Therapeutics, Inc. 6.31%7.751.8%$180.92m
ALNYAlnylam Pharmaceuticals, Inc. -0.87%159.038.5%$162.24m
INCYIncyte Corp. -0.37%107.872.5%$160.73m

Company Profile

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.